OsseoGraft Allograft* can alleviate the need for a second operative site when faced with inadequate autogenous bone size, shape or volume, thus preventing increased post-operative pain and donor site morbidity.
Our tissue bank is specialized in the processing of living donor tissue for dental use. The importance of bone substitute materials of human origin is increasing daily all around the world. Fully traceable tissue, origin and the safety of the final products are of utmost importance and must be granted by approved tissue banks. The OsseoGraft process, uses volatile agents only, and has been proven to eliminate potential pathogens, without destroying the natural bone structure. Thus, OsseoGraft allografts exhibit excellent biocompatibility and outstanding handling properties without even a suspected case of disease transmission.